According to our latest research, the global cancer biomarkers market size reached USD 17.4 billion in 2024, reflecting robust growth driven by technological advancements and increasing cancer prevalence worldwide. The market is forecasted to grow at a CAGR of 12.3% from 2025 to 2033, propelling the market value to approximately USD 49.2 billion by 2033. This strong growth trajectory is primarily attributed to the rising demand for early cancer detection, personalized medicine, and the expanding pipeline of biomarker-based diagnostic and therapeutic products. https://growthmarketreports.com/report/cancer-biomarkers-market-europe-industry-analysis